Share of Clicks for top 10 US Pharma & Biotech Pharmacology brands
Here are the Top 10 competitors in the industry by Share of Clicks for the last month.
| Domain | Share of clicks |
|---|---|
| lilly.com | 10.57 |
| ro.co | 10.54 |
| joinfridays.com | 6.96 |
| ivyrx.com | 4.97 |
| forbes.com | 4.7 |
| medvi.org | 3.95 |
| gobioverse.com | 3.21 |
| maxlife.com | 2.92 |
| webmd.com | 2.59 |
| wegovy.com | 2.41 |
| others | 47.18 |
- lilly.com - 10.57%
- ro.co - 10.54%
- joinfridays.com - 6.96%
- ivyrx.com - 4.97%
- forbes.com - 4.7%
- medvi.org - 3.95%
- gobioverse.com - 3.21%
- maxlife.com - 2.92%
- webmd.com - 2.59%
- wegovy.com - 2.41%
- others - 47.18%
Copyright © Adthena. All rights reserved.
In the PPC landscape, ‘lilly.com’ and ‘ro.co’ lead with 10.57% and 10.54% click shares, respectively. ‘Others’ dominate with 47.18%, showcasing diverse competition.
Share of Spend for the top 10 US Pharma & Biotech Pharmacology brands
Curious about your market position? Here you can see the Top 10 competitors in the industry by Share of Spend for the last month.
| Date | lilly.com | ro.co | joinfridays.com | maxlife.com | ivyrx.com | agelessrx.com | medvi.org | forbes.com | gobioverse.com | webmd.com |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026/03/01 | 9.64% | 14.96% | 0.59% | 6.26% | 6.44% | 0.12% | 3.09% | 10.91% | 0% | 8.93% |
| 2026/03/02 | 18.1% | 8.87% | 0.86% | 5.4% | 6.92% | 0.02% | 4.28% | 5.48% | 0.28% | 7.6% |
| 2026/03/03 | 18.86% | 15.81% | 2.15% | 5.53% | 7.93% | 0.59% | 4.88% | 5.1% | 2.3% | 7.57% |
| 2026/03/04 | 6.9% | 14.04% | 7.07% | 3.03% | 8.23% | 1.51% | 5.42% | 7.32% | 3.35% | 1.51% |
| 2026/03/05 | 5.39% | 13.51% | 8% | 6.37% | 8.99% | 2.5% | 4.23% | 6.48% | 10.43% | 1% |
| 2026/03/06 | 10% | 10.79% | 8.57% | 4.44% | 6.22% | 1.38% | 1.5% | 3.69% | 6.87% | 2.3% |
| 2026/03/07 | 8.43% | 10% | 10.04% | 4.67% | 3.3% | 1.84% | 7.7% | 3.38% | 10.73% | 3.01% |
| 2026/03/08 | 4.91% | 7.11% | 15.1% | 4.61% | 5.58% | 1.47% | 6.48% | 3.36% | 7.69% | 1.91% |
| 2026/03/09 | 4.45% | 6.17% | 16.03% | 6.28% | 4.6% | 2.24% | 5.83% | 3.97% | 8.77% | 3.27% |
| 2026/03/10 | 4.82% | 6.41% | 19.54% | 7.05% | 6.65% | 2.52% | 3.33% | 2.89% | 10.9% | 1.11% |
| 2026/03/11 | 11.21% | 14.24% | 7.57% | 2.74% | 2.93% | 0.29% | 4.42% | 2.84% | 2.23% | 2.6% |
| 2026/03/12 | 6.47% | 9.76% | 7.48% | 3.02% | 3.44% | 0.82% | 2.73% | 3.3% | 4.45% | 3.09% |
| 2026/03/13 | 9.51% | 14.27% | 11.92% | 4.19% | 3.6% | 2.23% | 3.69% | 4.28% | 1.99% | 3.39% |
| 2026/03/14 | 10.36% | 11.04% | 11.71% | 4.73% | 1.84% | 1.76% | 4.32% | 5.21% | 2.38% | 2.48% |
| 2026/03/15 | 10.59% | 12.18% | 7.8% | 2.41% | 2.85% | 1.56% | 3.35% | 5.25% | 1.57% | 2.58% |
| 2026/03/16 | 12.65% | 12.72% | 6.3% | 1.69% | 2.63% | 2.78% | 4.25% | 7.68% | 1.7% | 2.43% |
| 2026/03/17 | 10.47% | 13.01% | 7.15% | 3.42% | 3.55% | 2.29% | 1.9% | 4.94% | 1.3% | 2.8% |
| 2026/03/18 | 9.5% | 13.99% | 7.71% | 5.13% | 6.01% | 2.18% | 1.91% | 5.81% | 2.76% | 3.06% |
| 2026/03/19 | 12.26% | 14.5% | 7.53% | 2.73% | 5.47% | 2.99% | 3.13% | 8.03% | 2.9% | 3.2% |
| 2026/03/20 | 11.64% | 12.1% | 10.46% | 4.79% | 5.18% | 2.88% | 5.81% | 6.21% | 3.3% | 1.31% |
| 2026/03/21 | 10.94% | 9.9% | 9.57% | 2.82% | 5.37% | 3.34% | 6.16% | 5.99% | 3.17% | 2.44% |
| 2026/03/22 | 9% | 10.23% | 9.27% | 3.69% | 6.18% | 2.87% | 6.71% | 6.54% | 3.24% | 1.92% |
| 2026/03/23 | 11.96% | 9.79% | 8.18% | 3.43% | 5.67% | 1.65% | 4.88% | 4.67% | 2.67% | 1.75% |
| 2026/03/24 | 12.02% | 10.5% | 14.14% | 4.74% | 6.56% | 2.97% | 3.76% | 5.52% | 2.28% | 1.75% |
| 2026/03/25 | 14.26% | 13.53% | 7.91% | 3.49% | 7.55% | 0.77% | 3.85% | 5.03% | 1.31% | 3.95% |
| 2026/03/26 | 13.48% | 12.97% | 10.51% | 4.42% | 7.5% | 1.37% | 4.31% | 4.47% | 2.65% | 1.94% |
| 2026/03/27 | 13.29% | 15.17% | 11.68% | 0.53% | 5.21% | 2.32% | 3.62% | 4.87% | 2.64% | 2.03% |
| 2026/03/28 | 10.86% | 13% | 12.74% | 0.01% | 5.91% | 2.87% | 4.23% | 4.89% | 2.85% | 2.45% |
| 2026/03/29 | 11.31% | 12.67% | 15.11% | 0.01% | 6.02% | 2.85% | 4.52% | 4.83% | 1.84% | 2.52% |
| 2026/03/30 | 12.71% | 15.32% | 10.39% | 0.96% | 5.78% | 3.36% | 4.21% | 5.25% | 2.46% | 4.68% |
| 2026/03/31 | 14.2% | 9.8% | 9.37% | 8.03% | 6.7% | 4.96% | 4.55% | 3.99% | 3.36% | 2.77% |
- lilly.com
- ro.co
- joinfridays.com
- maxlife.com
- ivyrx.com
- agelessrx.com
- medvi.org
- forbes.com
- gobioverse.com
- webmd.com
Copyright © Adthena. All rights reserved.
In March 2026, lilly.com saw fluctuating PPC spend, peaking mid-month. Ro.co maintained a steady presence, while joinfridays.com surged early on. Maxlife.com experienced a late spike, and ivyrx.com remained consistent. Agelessrx.com and medvi.org showed gradual increases, whereas forbes.com and gobioverse.com had varied trends. Webmd.com ended with a notable rise.
Competitor Count for US Pharma & Biotech Pharmacology
Ever wondered how many competitors you’re up against in your industry? Well look no further, here we can see the number of advertisers bidding over the last month.
| Date | Competitor Count |
|---|---|
| 2026/03/01 | 365 |
| 2026/03/02 | 362 |
| 2026/03/03 | 371 |
| 2026/03/04 | 373 |
| 2026/03/05 | 360 |
| 2026/03/06 | 380 |
| 2026/03/07 | 368 |
| 2026/03/08 | 374 |
| 2026/03/09 | 370 |
| 2026/03/10 | 356 |
| 2026/03/11 | 354 |
| 2026/03/12 | 357 |
| 2026/03/13 | 383 |
| 2026/03/14 | 370 |
| 2026/03/15 | 371 |
| 2026/03/16 | 371 |
| 2026/03/17 | 410 |
| 2026/03/18 | 381 |
| 2026/03/19 | 392 |
| 2026/03/20 | 386 |
| 2026/03/21 | 375 |
| 2026/03/22 | 397 |
| 2026/03/23 | 385 |
| 2026/03/24 | 353 |
| 2026/03/25 | 363 |
| 2026/03/26 | 359 |
| 2026/03/27 | 351 |
| 2026/03/28 | 348 |
| 2026/03/29 | 338 |
| 2026/03/30 | 328 |
| 2026/03/31 | 335 |
Copyright © Adthena. All rights reserved.
March began with 365 advertisers, fluctuating throughout. A peak of 410 on March 17th marked the highest point. The month concluded with a decline, ending at 335 advertisers.
